Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia.

Baker M, Strongosky AJ, Sanchez-Contreras MY, Yang S, Ferguson W, Calne DB, Calne S, Stoessl AJ, Allanson JE, Broderick DF, Hutton ML, Dickson DW, Ross OA, Wszolek ZK, Rademakers R.

Neurogenetics. 2014 Mar;15(1):23-30. doi: 10.1007/s10048-013-0378-5. Epub 2013 Oct 18.

2.

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.

de la Fuente-Fernández R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ.

Ann Neurol. 2011 May;69(5):803-10. doi: 10.1002/ana.22284. Epub 2011 Jan 18.

PMID:
21246604
3.

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.

Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, Lee CS, McKenzie J, McCormick S, Samii A, Troiano A, Ruth TJ, Sossi V, de la Fuente-Fernandez R, Calne DB, Stoessl AJ.

Brain. 2009 Nov;132(Pt 11):2970-9. doi: 10.1093/brain/awp209. Epub 2009 Aug 18.

PMID:
19690093
4.

DCTN1 mutations in Perry syndrome.

Farrer MJ, Hulihan MM, Kachergus JM, Dächsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilariño-Güell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK.

Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.

5.

Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.

Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J.

Parkinsonism Relat Disord. 2009 Aug;15(7):539-41. doi: 10.1016/j.parkreldis.2008.10.008. Epub 2008 Nov 28.

PMID:
19041274
6.

Pallidonigral TDP-43 pathology in Perry syndrome.

Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK.

Parkinsonism Relat Disord. 2009 May;15(4):281-6. doi: 10.1016/j.parkreldis.2008.07.005. Epub 2008 Aug 23.

7.

The role of the Lewy body in idiopathic Parkinsonism.

de la Fuente-Fernandez R, Schulzer M, Mak E, Kishore A, Calne DB.

Parkinsonism Relat Disord. 1998 Aug;4(2):73-7.

PMID:
18591092
8.

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.

Wszolek ZK, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, Berry K, Calne DB, Vingerhoets FJ, Klein C, Pfeiffer RF.

Parkinsonism Relat Disord. 1997 Nov;3(3):125-39.

PMID:
18591067
9.

Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.

Miklossy J, Qing H, Guo JP, Yu S, Wszolek ZK, Calne D, McGeer EG, McGeer PL.

Acta Neuropathol. 2007 Sep;114(3):243-54. Epub 2007 Jul 17.

PMID:
17639429
10.

Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA.

Am J Hum Genet. 2007 Apr;80(4):769-78. Epub 2007 Mar 8.

11.

The natural history of neurological manganism over 18 years.

Huang CC, Chu NS, Lu CS, Chen RS, Schulzer M, Calne DB.

Parkinsonism Relat Disord. 2007 Apr;13(3):143-5. Epub 2006 Oct 17.

PMID:
17052946
12.

Autosomal dominant dystonia-plus with cerebral calcifications.

Wszolek ZK, Baba Y, Mackenzie IR, Uitti RJ, Strongosky AJ, Broderick DF, Baker MC, Melquist S, Hutton ML, Tsuboi Y, Allanson JE, Carr J, Kumar A, Calne SM, Miklossy J, McGeer PL, Calne DB, Stoessl AJ.

Neurology. 2006 Aug 22;67(4):620-5.

PMID:
16924015
13.

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ.

Brain. 2005 Dec;128(Pt 12):2777-85. Epub 2005 Aug 4.

PMID:
16081470
14.

A reassessment of the Lewy body.

Au WL, Calne DB.

Acta Neurol Taiwan. 2005 Jun;14(2):40-7. Review.

PMID:
16008161
15.

Severe vascular disturbance in a case of familial brain calcinosis.

Miklossy J, Mackenzie IR, Dorovini-Zis K, Calne DB, Wszolek ZK, Klegeris A, McGeer PL.

Acta Neuropathol. 2005 Jun;109(6):643-53. Epub 2005 Jun 4.

PMID:
15937691
16.

A definition of Parkinson's disease.

Calne D.

Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S39-40. Review.

PMID:
15885627
17.

Treatment for the progression of Parkinson's disease.

Calne D, Schulzer M, Mak E, Stoessl AJ.

Lancet Neurol. 2005 Apr;4(4):206. No abstract available.

PMID:
15778097
18.

Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).

Oliveira JR, Spiteri E, Sobrido MJ, Hopfer S, Klepper J, Voit T, Gilbert J, Wszolek ZK, Calne DB, Stoessl AJ, Hutton M, Manyam BV, Boller F, Baquero M, Geschwind DH.

Neurology. 2004 Dec 14;63(11):2165-7.

PMID:
15596772
19.

Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.

Lee CS, Schulzer M, de la Fuente-Fernández R, Mak E, Kuramoto L, Sossi V, Ruth TJ, Calne DB, Stoessl AJ.

Arch Neurol. 2004 Dec;61(12):1920-5.

PMID:
15596613
20.
21.

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Müller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T.

Neuron. 2004 Nov 18;44(4):601-7.

22.

Functional imaging in Tourette's syndrome.

Adams JR, Troiano AR, Calne DB.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1495-506. Epub 2004 Jun 30. Review.

PMID:
15480848
23.

A tribute for Prof. Dr. Melvin D. Yahr, M.D. (1917-2004).

Riederer PF, Hirsch E, Youdim MB, Calne DB.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1205-8. No abstract available.

PMID:
15480833
24.

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.

de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ.

Brain. 2004 Dec;127(Pt 12):2747-54. Epub 2004 Aug 25.

PMID:
15329355
25.

Clustering of Parkinson disease: shared cause or coincidence?

Kumar A, Calne SM, Schulzer M, Mak E, Wszolek Z, Van Netten C, Tsui JK, Stoessl AJ, Calne DB.

Arch Neurol. 2004 Jul;61(7):1057-60.

PMID:
15262735
26.

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).

Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, Singleton A, Bower J, Utti RJ, Bird TD, de la Fuente-Fernandez R, Tsuboi Y, Klimek ML, Suchowersky O, Hardy J, Calne DB, Wszolek ZK, Farrer M, Gwinn-Hardy K, Stoessl AJ.

Mov Disord. 2004 Jun;19(6):622-9. Review.

PMID:
15197699
27.

The neuromythology of Parkinson's Disease.

Calne DB, Mizuno Y.

Parkinsonism Relat Disord. 2004 Jul;10(5):319-22. Review.

PMID:
15196512
28.

Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.

Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Müller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW.

Neurology. 2004 May 11;62(9):1619-22.

PMID:
15136696
29.

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.

de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ.

Brain. 2004 Apr;127(Pt 4):888-99. Epub 2004 Feb 11.

PMID:
14960500
30.

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Zimprich A, Müller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T.

Am J Hum Genet. 2004 Jan;74(1):11-9. Epub 2003 Dec 19. Erratum in: Am J Hum Genet. 2004 Sep;75(3):534.

31.

Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease.

Chen X, Liu W, Guoyuan Y, Liu Z, Smith S, Calne DB, Chen S.

Parkinsonism Relat Disord. 2003 Oct;10(1):1-7.

PMID:
14499199
32.

Determination of an occupational exposure guideline for manganese using the benchmark method.

Clewell HJ, Lawrence GA, Calne DB, Crump KS.

Risk Anal. 2003 Oct;23(5):1031-46.

PMID:
12969417
33.

Progressive supranuclear palsy as a cause of balance disorders.

Kaur H, Westerberg BD, Mallinson A, Calne D.

J Otolaryngol. 2003 Apr;32(2):114-7. No abstract available.

PMID:
12866597
34.

VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.

De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ.

Synapse. 2003 Jul;49(1):20-8.

PMID:
12710012
36.

Familial and sporadic Parkinson's disease usually display the same clinical features.

Carr J, de la Fuente-Fernández R, Schulzer M, Mak E, Calne SM, Calne DB.

Parkinsonism Relat Disord. 2003 Mar;9(4):201-4.

PMID:
12618054
37.

Age and severity of nigrostriatal damage at onset of Parkinson's disease.

De La Fuente-Fernández R, Lim AS, Sossi V, Adam MJ, Ruth TJ, Calne DB, Stoessl AJ, Lee CS.

Synapse. 2003 Feb;47(2):152-8.

PMID:
12454953
38.

SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.

Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernández R, Hussey J, Lockhart P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek ZK.

Neurology. 2002 Nov 26;59(10):1625-7.

PMID:
12451209
39.

Parkinson's disease over the last 100 years.

Calne DB.

Adv Neurol. 2003;91:1-8. No abstract available.

PMID:
12442659
40.

Dopamine release in human ventral striatum and expectation of reward.

de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ.

Behav Brain Res. 2002 Nov 15;136(2):359-63.

PMID:
12429397
41.

[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.

Pal PK, Leung J, Hedrich K, Samii A, Lieberman A, Nausieda PA, Calne DB, Breakefield XO, Klein C, Stoessl AJ.

Mov Disord. 2002 Jul;17(4):789-94.

PMID:
12210877
42.

Evidence for environmental causation of Parkinson's disease.

de la Fuente-Fernández R, Calne DB.

Parkinsonism Relat Disord. 2002 Mar;8(4):235-41.

PMID:
12039417
43.

Synthetic dopamine agonists.

Calne DB.

Expert Opin Pharmacother. 2002 Apr;3(4):363-4. Review. No abstract available.

PMID:
11934338
44.

Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.

de La Fuente-Fernández R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, Stoessl AJ.

J Cereb Blood Flow Metab. 2001 Oct;21(10):1151-9.

PMID:
11598492
45.

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.

de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ.

Science. 2001 Aug 10;293(5532):1164-6.

46.

Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes.

Pal PK, Wszolek ZK, Uitti R, Markopoulou K, Calne SM, Stoessl AJ, Calne DB.

Parkinsonism Relat Disord. 2001 Sep;8(1):51-6. Review.

PMID:
11472880
47.

The long-term response to levodopa in dopa-responsive dystonia.

Hwang WJ, Calne DB, Tsui JK, de la Fuente-Fernández R.

Parkinsonism Relat Disord. 2001 Sep;8(1):1-5.

PMID:
11472874
48.

Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.

Hutton JT, Metman LV, Chase TN, Juncos JL, Koller WC, Pahwa R, LeWitt PA, Samii A, Tsui JK, Calne DB, Waters CH, Calabrese VP, Bennett JP, Barrett R, Morris JL.

Mov Disord. 2001 May;16(3):459-63.

PMID:
11391739
49.

Daytime somnolence in patients with Parkinson's disease.

Sanjiv CC, Schulzer M, Mak E, Fleming J, Martin WR, Brown T, Calne SM, Tsui J, Stoessl AJ, Lee CS, Calne DB.

Parkinsonism Relat Disord. 2001 Oct;7(4):283-286.

PMID:
11344010
50.

Familial aggregation of Parkinson's disease.

de la Fuente-Fernández R, Calne DB.

N Engl J Med. 2001 Apr 12;344(15):1168. No abstract available.

PMID:
11302144

Supplemental Content

Support Center